Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment

Brain Research

Volumn 1180, Issue 1, 2007, Pages 140-154

  Wasserman, Jason K ^a,b   Zhu, Xiaoping ^a   Schlichter, Lyanne C ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Inflammatory cytokines, inflammatory proteins; Inflammatory proteins; Interleukin 1; Matrix metalloproteases; Stroke genes; Tumor necrosis factor

Indexed keywords

COLLAGENASE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE ELASTASE; MESSENGER RNA; MINOCYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HEMORRHAGE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN; BRAIN INJURIES; CEREBRAL HEMORRHAGE; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASES; MINOCYCLINE; NERVE TISSUE PROTEINS; NEUROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

RATTUS;

EID: 35548966601     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.058     Document Type: Article

References (55)

1. Abilleira S., Montaner J., Molina C.A., Monasterio J., Castillo J., and Alvarez-Sabin J. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J. Neurosurg. 99 (2003) 65-70
2. Alvarez-Sabin J., Delgado P., Abilleira S., Molina C.A., Arenillas J., Ribo M., Santamarina E., Quintana M., Monasterio J., and Montaner J. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35 (2004) 1316-1322
3. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19 (1999) 819-834
4. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
5. Brett F.M., Mizisin A.P., Powell H.C., and Campbell I.L. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 54 (1995) 766-775
6. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2 (1996) 788-794
7. Bustin S.A., and Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 15 (2004) 155-166
8. Chandler S., Cossins J., Lury J., and Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228 (1996) 421-429
9. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M., and Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31 (2000) 1715-1720
10. Fagan S.C., Edwards D.J., Borlongan C.V., Xu L., Arora A., Feuerstein G., and Hess D.C. Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp. Neurol. 186 (2004) 248-251
11. Felberg R.A., Grotta J.C., Shirzadi A.L., Strong R., Narayana P., Hill-Felberg S.J., and Aronowski J. Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann. Neurol. 51 (2002) 517-524
12. Feuerstein G.Z., Wang X., and Barone F.C. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 5 (1998) 143-159
13. Hummel V., Kallmann B.A., Wagner S., Fuller T., Bayas A., Tonn J.C., Benveniste E.N., Toyka K.V., and Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J. Neuropathol. Exp. Neurol. 60 (2001) 320-327
14. Kallmann B.A., Wagner S., Hummel V., Buttmann M., Bayas A., Tonn J.C., and Rieckmann P. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 16 (2002) 589-591
15. Lee J.E., Yoon Y.J., Moseley M.E., and Yenari M.A. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J. Neurosurg. 103 (2005) 289-297
16. Leira R., Davalos A., Silva Y., Gil-Peralta A., Tejada J., Garcia M., and Castillo J. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63 (2004) 461-467
17. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., and Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
18. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
19. Loddick S.A., Turnbull A.V., and Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 176-179
20. Lu A., Tang Y., Ran R., Ardizzone T.L., Wagner K.R., and Sharp F.R. Brain genomics of intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 26 (2006) 230-252
21. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 Suppl 1 (2006) S232-S240
22. Maier C.M., Hsieh L., Crandall T., Narasimhan P., and Chan P.H. Evaluating therapeutic targets for reperfusion-related brain hemorrhage. Ann. Neurol. 59 (2006) 929-938
23. Masada T., Hua Y., Xi G., Yang G.Y., Hoff J.T., and Keep R.F. Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J. Neurosurg. 95 (2001) 680-686
24. Moss M.L., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
25. Mulcahy N.J., Ross J., Rothwell N.J., and Loddick S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 140 (2003) 471-476
26. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
27. Penkowa M., Giralt M., Lago N., Camats J., Carrasco J., Hernandez J., Molinero A., Campbell I.L., and Hidalgo J. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp. Neurol. 181 (2003) 130-148
28. Power C., Henry S., Del Bigio M.R., Larsen P.H., Corbett D., Imai Y., Yong V.W., and Peeling J. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53 (2003) 731-742
29. Qureshi A.I., Suri M.F., Ostrow P.T., Kim S.H., Ali Z., Shatla A.A., Guterman L.R., and Hopkins L.N. Apoptosis as a form of cell death in intracerebral hemorrhage. Neurosurgery 52 (2003) 1041-1047
30. Rosell A., Ortega-Aznar A., Alvarez-Sabin J., Fernandez-Cadenas I., Ribo M., Molina C.A., Lo E.H., and Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37 (2006) 1399-1406
31. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
32. Rosenberg G.A., Mun-Bryce S., Wesley M., and Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 21 (1990) 801-807
33. Silva Y., Leira R., Tejada J., Lainez J.M., Castillo J., and Davalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 36 (2005) 86-91
34. Singhal A., Baker A.J., Hare G.M., Reinders F.X., Schlichter L.C., and Moulton R.J. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J. Neurotrauma 19 (2002) 929-937
35. Stirling D.P., Koochesfahani K.M., Steeves J.D., and Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 11 (2005) 308-322
36. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57 (1999) 563-581
37. Stroemer R.P., and Rothwell N.J. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 833-839
38. Szymanska A., Biernaskie J., Laidley D., Granter-Button S., and Corbett D. Minocycline and intracerebral hemorrhage: influence of injury severity and delay to treatment. Exp. Neurol. 197 (2006) 189-196
39. Tang Y., Lu A., Aronow B.J., Wagner K.R., and Sharp F.R. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur. J. Neurosci. 15 (2002) 1937-1952
40. Tejima E., Zhao B.Q., Tsuji K., Rosell A., van L.K., Gonzalez R.G., Montaner J., Wang X., and Lo E.H. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J. Cereb. Blood Flow Metab. 27 (2007) 460-468
41. Tsuji M., Wilson M.A., Lange M.S., and Johnston M.V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189 (2004) 58-65
42. Vila N., Castillo J., Davalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
43. Wang J., and Dore S. Inflammation after intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 27 (2007) 894-908
44. Wang J., and Tsirka S.E. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128 (2005) 1622-1633
45. Wasserman J.K., Schlichter L.C., in press. Minocycline protects the blood-brain barrier and reduces edema following intracerebral hemorrhage in the rat. Exp. Neurol. doi:10.1016/j.expneurol.2007.06.025.
46. Wasserman J.K., and Schlichter L.C. Neuron death and inflammation in a rat model of intracerebral hemorrhage: effects of delayed minocycline treatment. Brain Res. 1136 (2007) 208-218
47. Wells J.E., Biernaskie J., Szymanska A., Larsen P.H., Yong V.W., and Corbett D. Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice. Eur. J. Neurosci. 21 (2005) 187-196
48. Wilson K.P., Black J.A., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., and Raybuck S.A. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370 (1994) 270-275
49. Xue M., and Del Bigio M.R. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 283 (2000) 230-232
50. Yang G.Y., Zhao Y.J., Davidson B.L., and Betz A.L. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res. 751 (1997) 181-188
51. Yenari M.A., Xu L., Tang X.N., Qiao Y., and Giffard R.G. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37 (2006) 1087-1093
52. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev., Neurosci. 2 (2001) 502-511
53. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., and Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15769-15774
54. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13496-13500
55. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445